Chung Sung-Woon, Lee Ji-Hyuk, Choi Kyung-Ha, Park Young-Chul, Eo Seong-Kug, Rhim Byung-Yong, Kim Koanhoi
Department of Thoracic and Cardiovascular Surgery, School of Medicine, Pusan National University, Busan, Republic of Korea.
Biochem Biophys Res Commun. 2009 Jan 16;378(3):444-9. doi: 10.1016/j.bbrc.2008.11.063. Epub 2008 Nov 24.
Oxidative stress results in sustained release of heat shock protein 90 (HSP90) from vascular smooth muscle cells (VSMCs). The aim of this article is to investigate whether extracellular HSP90 predisposes VSMCs to pro-inflammatory phenotype. Exposure of aortic smooth muscle cells to HSP90 elevated IL-8 release and IL-8 transcript via promoter activation. HSP90-induced IL-8 promoter activation was suppressed by dominant-negative forms of Toll-like receptor (TLR)-4 and MyD88, but not by dominant-negative-forms of TLR-3, TLR-2, and TRIF. IL-8 up-regulation in response to HSP90 was also attenuated by IkappaB, rasveratrol, curcumin, diphenyleneiodium, N-acetylcystein, U0126, and SB202190. Mutation at the NF-kappaB- or C/EBP-binding site, but not at the AP-1-binding site, in the IL-8 promoter region suppressed the promoter activation by HSP90. This study proposes that extracellular HSP90 would contribute to IL-8 elevation in the stressed vasculature, and that TLR-4, mitogen-activated protein kinases, NF-kappaB, and reactive oxygen species are involved in that process.
氧化应激导致热休克蛋白90(HSP90)从血管平滑肌细胞(VSMC)持续释放。本文旨在研究细胞外HSP90是否使VSMC倾向于促炎表型。将主动脉平滑肌细胞暴露于HSP90可通过启动子激活提高白细胞介素-8(IL-8)的释放和IL-8转录本水平。Toll样受体(TLR)-4和髓样分化因子88(MyD88)的显性负性形式可抑制HSP90诱导的IL-8启动子激活,但TLR-3、TLR-2和TRIF的显性负性形式则不能。IkappaB、白藜芦醇、姜黄素、二苯碘鎓、N-乙酰半胱氨酸、U0126和SB202190也可减弱VSMC对HSP90的IL-8上调反应。IL-8启动子区域中核因子κB(NF-κB)或CCAAT/增强子结合蛋白(C/EBP)结合位点的突变可抑制HSP90对启动子的激活,而激活蛋白-1(AP-1)结合位点的突变则无此作用。本研究表明,细胞外HSP90可能导致应激血管中IL-8水平升高,且TLR-4、丝裂原活化蛋白激酶、NF-κB和活性氧参与了这一过程。